Survivor Profile: Tricia Riffenburgh, Stage IV Melanoma
By Mara Klecker It is with heavy hearts that we must update this post to inform you that Tricia passed…
08/28/2023
Survivor Profile: Tricia Riffenburgh, Stage IV Melanoma
By Mara Klecker It is with heavy hearts that we must update this post to inform you that Tricia passed…
08/15/2023
Clinical Trials Catch Up
Welcome to our new interview series called Clinical Trials Catch Up, an article delivered in a question-and-answer format designed to…
|
08/08/2023
Dealing with the Emotional Rollercoaster that Follows a Melanoma Diagnosis PART II with guest host, Melissa Wilson, PA-C, MPAS, UPMC Hillman Cancer Center
Receiving a melanoma diagnosis can be an overwhelming and life-altering experience. The emotional rollercoaster that follows can be intense, as…
|
08/01/2023
AIM’s Latest Newsletter: The Research Edition, July 2023
This month’s newsletter focuses on the latest news and scientific breakthroughs in melanoma research. This edition features: Letter from AIM’s…
|
07/09/2023
I’ve Been Diagnosed With Melanoma…Now What? PART I with guest host, Melissa Wilson, PA-C, MPAS, UPMC Hillman Cancer Center
The test results are back. You’ve talked to the doctor and learned you have melanoma. Whether it’s your first or…
|
06/27/2023
ASCO Update 2023
What is ASCO? ASCO is the abbreviation for the American Society of Clinical Oncology, and it is simply the professional…
|
06/26/2023
Jim Zeoli Had Never Spent Much Time Thinking About Melanoma—Until He Was Diagnosed
by Mara Klecker Jim Zeoli had never spent much time thinking about melanoma before his own diagnosis at the end…
|
06/20/2023
Reva Foy: Living Her Best Life, Despite Melanoma
By Mara Klecker At first, Reva Foy assumed the open wound on her right foot could be attributed to a…
|
06/06/2023
Why Peer Support is Important for People Coping With Melanoma
People living with melanoma often benefit from practical help and advice from others who have lived through similar situations. Support…
|
05/30/2023
Iovance Biotherapeutics Announces U.S. Food and Drug Administration Acceptance of the Biologics License Application of Lifileucel for the Treatment of Advanced Melanoma
May 26, 2023 17:30 ET| Source: Iovance Biotherapeutics, Inc. Priority Review Granted with Prescription Drug User Fee Act (PDUFA) Action Date…
|
|
Recent Posts
Dec. 12, 2024
Navigating Melanoma Together: 2024 Podcast Wrap-Up
Dec. 10, 2024
Beyond the Clinic’s New Host: Introducing Dr. Sam Siegel
Dec. 09, 2024
Managing Melanoma During the Holiday Season
Dec. 05, 2024
Beyond the Clinic’s New Host: Dr. Sam Siegel Brings a Fresh Voice to Survivorship
Dec. 03, 2024